Novel human malignancy-associated gene (MAG) expressed in various tumors and in some tumor preexisting conditions

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4475-4479

  Ljubimova, Julia Y ^a   Wilson, Steven E ^b   Petrovic, Lidija M ^a   Ehrenman, Karen ^a   Ljubimov, Alexander V ^a   Demetriou, Achilles A ^a   Geller, Stephen A ^a   Black, Keith L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; GENE SEQUENCE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS HEPATITIS;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN; BRAIN NEOPLASMS; CARCINOMA, HEPATOCELLULAR; EMBRYO; FEMALE; GLIOBLASTOMA; HEPATITIS B; HEPATITIS C; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREGNANCY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032189536     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hunter, T. Cooperation between oncogenes. Cell, 64: 249-270, 1991.
2. Hunter, T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell, 80: 225-236, 1995.
3. Chu, T. M. Molecular diagnosis of pancreas carcinoma. J. Clin. Lab. Anal., 11: 225-231, 1997.
4. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
5. Payletti, G., Godolphin, W., Press, M. F., Slamon, D. J. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. 13: 63-72, 1996.
6. Becker, C., and Lilja, H. Individual prostate-specific antigen (PSA) forms as prostate tumor markers. Clin. Chim. Acta, 257: 117-132, 1997.
7. Seeff, L. B. Liver development. In: D. Zakim and T. D. Boyer (eds.), Hepatology: A Textbook of Liver Disease, pp. 958-1003. Philadelphia: W. B. Saunders, 1990.
8. Tanaka, Y. Y., Ozawa, Y., Tsukada, N., Inada, S., Inagaki, Y., Miyamoto, K., Suzuki, O., Okawa, H., and Kiryu, Y. Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors. Liver, 12: 90-93, 1992.
9. Su, T-S., Liu, W-Y., Han, S-H., Jamsen, M., Yang-Fen, T., P'eng, F-K., and Chou, C-K. Transcripts of the insulin-like growth factors I and II in human hepatoma. Cancer Res., 49: 1773-1777, 1989,
10. Yang, D., Alt, E., and Rogler, C. E. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res., 53: 2020-2027, 1993.
11. Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., and Bishop, M. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in colon carcinoma. Proc. Natl. Acad. Sci. USA, 80: 1707-1717, 1983.
12. Sehgal, A. Molecular changes during the genesis of human gliomas. Semin. Surg. Oncol., 14: 3-12, 1998.
13. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
14. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
15. Ljubimova, J. Y., Petrovic, L. M., Wilson, S. E., Geller, S. A., and Demetriou, A. A. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J. Histochem. Cytochem., 45: 79-87, 1997.
16. Ljubimova, J. Y., Petrovic, L. M., Geller, S. A., and Demetriou, A. A. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation. Dig. Dis. Sci., 42: 1675-1680, 1997.
17. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: a Laboratory Manual, pp. 7.37-7.84. Cold Spring Harbor: Cold Spring Harbor Laboratory. 1989.
18. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, R. E., Seidman, J. G., Smith, J. A., and Struhl, K. (eds.) Current Protocols in Molecular Biology, pp. 4.6-4.10. New York: J. Wiley & Sons, 1987.
19. Lamerdin, J. E., Stilwagen, S. A., Ramirez, M. H., Stubbs, L., and Carrano, A. V. Sequence analysis of the ERCC2 gene regions in human, mouse and hamster reveals three linked genes. Genomics, 34: 399-409, 1996.
20. Ross, J. S., Sheehan, C., Hayner-Buchan, A. M., Ambros, R. A., Kallakury, B. V., Kaufman, R., Fisher, H. A., and Muraca, P. J. HER-2 neu gene amplification status in prostate cancer by fluorescence in situ hybridization. Hum. Pathol., 28: 827-833, 1997.
21. Diamandis, E. P., and Yu, H. Nonprostatic sources of prostate-specific antigen. Urol. Clin. North Am., 24: 275-282, 1997.
22. Cioce, V., Csaky, K. G., Chan, A. M-L., Bottaro, D. P., Taylor, W. G., Jensen, R., Aaronson, S. A., and Rubin, J. S. Hepatocyte growth factor (HGF)NK1 is a naturally occurring HGF/Scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem., 271: 13110-13115, 1996.
23. Damjanov, I. Teratocarcinoma. Neoplastic lessons about normal embryogenesis. Int. J. Dev. Biol., 37: 39-46, 1993.
24. Yen, Y-C., Tsai, L-F., Chuang, L-Y., Yen, H-W., Tsai, J-H., Florine, D. L., and Tam, J. P. Elevation of transforming growth factor α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res., 47: 896-901, 1987.
25. Carr, B. I., and Michalopoulos, G. K. Biology of human hepatocellular carcinoma. In: C. Brechot (ed). Primary Liver Cancer: Etiological and Progression Factors, pp. 249-268. Boca Raton: CRC Press, 1994.
26. Mishima, K., Asia, A., Kadomatsu, K., Ino, Y., Nomura, K., Narita, Y., Muramatsu, T., and Kirino, T. Increased expression of midkine during the progression of human astrocytomas. Neurosci. Lett., 12: 29-32, 1997.
27. Desbaillets, I., Tada, M., de Tribolet, N., Diserens, A. C., Hamou, M. F., and Van Meir, E. G. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer. 58: 240-247, 1994.